Friday 6 November 2026 Export GSK’s income statement to Excel — free account

GSK PLC Sponsored ADR

GSK Healthcare Drug Manufacturers General

GSK PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $43.1 billion, up 7.44% from fiscal 2024.

Revenue: +3.75%
EPS: −14.7%
Free cash flow: +62.4%
Total debt: +33.2%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

50.19 0.22 −0.44%

Follow GSK

Alert me

Market cap: $101.0B
P/E: 16.7×
Fwd P/E: 14.6×
Dividend yield: 3.60%
F-score: 9/9
Altman Z: 2.12
Beneish M: −2.46
Dividend safety: 54/100

Overview

GSK PLC Sponsored ADR (GSK) Current ratio

Alert me on Current ratio

GSK PLC Sponsored ADR's current ratio at the end of the quarter to 30 September 2026 was 0.9×, up 0.0× from fiscal 2025 (0.8×). Over the past ten years it has ranged from 0.6× (fiscal 2017) to 1.2× (fiscal 2015); the current reading is higher than 55% of that period. That is below the Drug Manufacturers General industry median of 1.4× and below the Healthcare sector median of 3.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/GSK/current-ratio" width="100%" height="360" style="border:0" loading="lazy" title="GSK PLC Sponsored ADR current ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/GSK/metrics/current-ratio">GSK PLC Sponsored ADR (GSK) current ratio — stockrow.com</a></p>

Period	Current ratio	Change
FY2025	0.8×	4.49%
FY2024	0.8×	(11.47%)
FY2023	0.9×	(2.81%)
FY2022	0.9×	15.41%
FY2021	0.8×	(13.71%)
FY2020	0.9×	12.81%
FY2019	0.8×	7.68%
FY2018	0.8×	25.71%
FY2017	0.6×	(31.93%)
FY2016	0.9×	(28.86%)

Period	Current ratio	Change
Sep 2026	0.9×	5.92%
Jun 2026	0.8×	2.97%
Mar 2026	0.8×	(3.26%)
Dec 2025	0.8×	(2.12%)
43 more quarters	Free account

Against its own ten years

Low 0.6× High 1.2×

Ten-year median 0.8×

Current reading's percentile 55

Company	Current ratio
BIIB Biogen Inc. compare	1.9×
BMY Bristol Myers Squibb Company compare	1.6×
AMGN Amgen Inc. compare	1.5×
PFE Pfizer Inc. compare	1.4×
GILD Gilead Sciences, Inc. compare	1.4×
SNY Sanofi compare	1.1×
AZN AstraZeneca PLC compare	1.0×
NVO Novo Nordisk A/S compare	0.9×
GSK GSK PLC Sponsored ADR	0.9×
Drug Manufacturers General industry median	1.4×
Healthcare sector median	3.1×
Market median	1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

GSK PLC Sponsored ADR (GSK) Current ratio

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on GSK

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on GSK

Stockrow Weekly